Sunesis to Present at Upcoming Investor Conferences
Cowen & Company34th Annual Health Care Conference Tuesday, March 4th at 10:40 AM Eastern Time The Boston Marriott Copley Place, Boston
Roth Conference Tuesday, March 11th at 10:00 AM Pacific Time
The Ritz Carlton,
Dana Point, CA
A live webcast of the presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit http://www.sunesis.com.
CONTACT: Investor and Media Inquiries:
David Pitts Argot Partners212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc.650-266-3717 Eliza Schleifstein Argot Partners917-763-8106 firstname.lastname@example.org